Tech Company Financing Transactions
Spinal Modulation Funding Round
De Novo Ventures, ePlanet Capital and Incubic Venture Capital participated in a $27.4 million Series C venture round for Spinal Modulation. The funding round was announced on 11/9/2009.
Transaction Overview
Company Name
Announced On
11/9/2009
Transaction Type
Venture Equity
Amount
$27,400,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1135 O'Brien Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
The Spinal Modulation Axium Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Wood
Chief Scientific Officer
Jeff Kramer
Chief Technical Officer
Lynn Elliott
VP - Marketing
Dan Brounstein
VP - Operations
Bob Gaffney
VP - Regulatory Affairs
Steven McQuillan
VP - Sales
Martin Chambers
Browse more venture capital transactions:
Prev: 11/9/2009: Penguin Computing venture capital transaction
Next: 11/9/2009: Element Labs venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs